Whether you have interest for a family member or friend that you would like to pursue engineering as a career choice or are just concerned about how future engineering students will be educated, the answer(s) to this question are extremely relevant. Of course, you could do a web search to see what has already been […]
TransEnterix wins FDA nod for Senhance robot-assisted surgery platform
TransEnterix (NYSE:TRXC) said last week that it won 510(k) clearance from the FDA for its Senhance robot-assisted surgery platform. TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clerarance bid last month after applying in April. “The clearance of the Senhance system in the U.S. is a milestone in the progress of robotics and is…
TransEnterix escapes shareholders lawsuit
TransEnterix (NYSE:TRXC) last week won the dismissal of a shareholders lawsuit brought over the collapse of its SurgiBot program, with a federal judge ruling that the company and its management and investors didn’t mislead shareholders about the robot-assisted surgery platform’s prospects with the FDA. The case dates back to the spring of 2016, when Research Triangle Park,…